Journal of Diabetes Research / 2016 / Article / Tab 2 / Research Article
Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis Table 2 Baseline characteristics of the enrolled studies.
Study ID Fasting glucose, mmol/L Fasting insulin, mIU/L C-peptide, nmol/L HOMA-IR HbA1c, % TC, mmol/L TG, mmol/L HDL-c, mmol/L LDL-c, mmol/L Ebert et al. (non-CD), 2014 [12 ] 7.60/5.10 6.88/6.48 NA 2.70/1.30 NA 4.90/5.30 1.40/1.10 1.20/1.40 2.90/3.50 Ebert et al. (CD), 2014 [12 ] 5.20/4.60 7.19/4.05 NA 1.40/0.80 NA 4.20/4.40 1.80/1.60 1.00/1.00 2.10/2.70 Fu et al., 2014 [11 , 19 ] 11.17/5.19 NA NA NA 9.20/NA 4.62/4.56 2.26/1.64 1.17/1.35 2.83/2.54 Fenzl et al., 2014 [20 ] 7.29/5.19 10.06/10.08 1.09/1.02 3.72/2.72 7.72/5.73 5.48/3.95 1.96/1.37 1.33/1.73 3.22/2.55
Chen et al., 2015[14 ] 8.70/4.90 6.81/4.31 NA 3.09/1.07 7.70/5.50 5.00/4.90 1.50/1.40 1.40/1.50 2.90/2.80 Espes et al., 2014 [21 ] 8.50/6.20 NA 1.20/0.98 3.10/2.30 6.80/5.80 4.55/6.18 1.45/1.54 1.18/1.46 2.80/3.98 Hu et al., 2014 [15 ] 9.99/5.06 8.27/7.16 NA NA 9.23/5.26 5.14/4.61 2.46/1.59 1.16/1.27 3.28/2.80 Gómez-Ambrosi et al., 2014 [13 ] 6.17/5.17 23.70/12.90 1.19/0.74 6.30/3.00 NA 5.22/5.04 2.39/1.21 1.37/1.40 2.77/3.08 Yamada et al., 2015 [16 ] 8.00/5.28 NA NA NA 8.8/5.2 5.40/5.15 2.16/1.90 1.16/1.42 3.39/3.28 Guo et al. (obese), 2015 [22 ] 7.41/5.16 21.00/16.58 2.84/3.08 6.91/3.93 7.59/5.56 4.95/5.16 2.10/1.89 0.96/1.24 3.01/3.22 Guo et al. (overweight), 2015 [22 ] 9.09/5.36 23.06/9.19 2.48/2.09 8.65/2.22 8.78/5.53 5.16/5.33 2.87/1.74 0.95/1.28 3.12/3.56 Guo et al. (lean), 2015 [22 ] 9.33/5.08 9.04/6.63 1.67/1.41 3.81/1.51 9.56/5.16 4.62/4.82 2.45/1.12 1.07/1.33 2.53/3.21
CD: chronic hemodialysis; HDL-c: high-density lipoprotein-cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; LDL-c: low-density lipoprotein-cholesterol; NA: not available; TC: total cholesterol; TG: triglyceride.
